Quality Management Maturity: FDA Vision & Expectations (8/15) Global Quality
Alex Viehmann, CDER Office of Pharmaceutical Quality, notes mature quality management systems are needed to advance pharmaceutical quality and reduce drug shortages and shares FDA’s vision for the future of quality management.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia
CDER SBIA 2020 Playlist: https://www.youtube.com/playlist?list=PLey4Qe-UxcxZiTopt4biuIyxmUQJDkaWb
LinkedIn: https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
Training resources: https://www.fda.gov/cderbsbialearn
Twitter: https://twitter.com/FDA_Drug_Info
CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionmanagement
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
Видео Quality Management Maturity: FDA Vision & Expectations (8/15) Global Quality канала U.S. Food and Drug Administration
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia
CDER SBIA 2020 Playlist: https://www.youtube.com/playlist?list=PLey4Qe-UxcxZiTopt4biuIyxmUQJDkaWb
LinkedIn: https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
Training resources: https://www.fda.gov/cderbsbialearn
Twitter: https://twitter.com/FDA_Drug_Info
CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionmanagement
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
Видео Quality Management Maturity: FDA Vision & Expectations (8/15) Global Quality канала U.S. Food and Drug Administration
Показать
Комментарии отсутствуют
Информация о видео
29 июля 2020 г. 17:55:44
00:20:13
Другие видео канала
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020Filing Review Basics – Examples of Refuse-to-Receive (RTR) (15of27) Generic Drugs Forum 2018LACF and Acidified Foods Regulations and RequirementsSubmitting IND Safety Reports to FDA Adverse Event Reporting System (FAERS)- Nov. 1, 2019FDA Study Data Technical Conformance Guide v4.4 - Nov 22, 2019Regulatory Highlights for Biosimilars and Interchangeables (9of15) REdI – May 29-30, 2019Your Report Matters! What You Can Report!Vaccines and Related Biological Products Advisory Committee – 6/15/2022Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 3Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 5Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 4Virtual Press Conference: Pediatric COVID-19 Vaccines – 6/17/2022Conversation on Cancer: National Black Family Cancer Awareness Week, Engaging the GenerationsMeeting of the Pharmacy Compounding Advisory Committee (PCAC)Alimenta tu mente: Diferencia entre azucares totales y añadidosFDA Stakeholder Webinar on Action Levels for Lead in Juice: Guidance for Industry72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1June 17, 2022 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 273nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1